leadf
logo-loader
viewOpen Orphan PLC

Open Orphan says Venn Life Sciences arm has started 2021 with significant contract renewal

Chairman Cathal Friel said: "We are delighted to enter 2021 with another contract signed by the Venn team in Breda with this top-three global pharmaceutical client"

Open Orphan PLC -

Open Orphan PLC (LON:ORPH) said a top-three global pharmaceuticals company has renewed its contract with the group's Venn Life Sciences division until the end of the year.

The team in the Breda office, in the Netherlands, will provide chemistry, manufacturing and control consultancy (CMC) services to one of the client's vaccine development programmes.

In a statement, Open Orhan chairman Cathal Friel said: "We are delighted to enter 2021 with another contract signed by the Venn team in Breda with this top-three global pharmaceutical client.

“Venn have been providing CMC support to this top tier company since 2012 and are pleased to be continuing to work with this client in their vaccine development programme.”

Quick facts: Open Orphan PLC

Price: 28.5 GBX

AIM:ORPH
Market: AIM
Market Cap: £190.78 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Open Orphan PLC named herein, including the promotion by the Company of Open Orphan PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Open Orphan to become '$1bln firm in very near future' after COVID-19 study...

Open Orphan PLC's (LON:ORPH) Cathal Friel talks to Proactive London's Katie Pilbeam about the world’s first COVID-19 characterisation study receiving approval from a specially convened Research Ethics Committee (REC).  This follows a contract received by the company’s subsidiary hVIVO...

2 weeks, 5 days ago

2 min read